The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
≤ 6 months postpartum
EPDS score >10
Current or past-year substance use disorder
Lifetime history of bipolar disorder or psychotic disorder
Active suicidal intent
Retinal pathology or history of eye surgery
University of Michigan
Lead sponsor
American Academy of Sleep Medicine
Collaborator